Hyperfine (NASDAQ:HYPR – Get Free Report) released its quarterly earnings data on Monday. The company reported ($0.14) earnings per share for the quarter, topping the consensus estimate of ($0.16) by $0.02, Zacks reports. The business had revenue of $2.32 million during the quarter, compared to analysts’ expectations of $2.30 million. Hyperfine had a negative return on equity of 57.54% and a negative net margin of 309.42%. During the same quarter last year, the business posted ($0.15) EPS. Hyperfine updated its FY 2025 guidance to EPS.
Hyperfine Stock Performance
Shares of HYPR stock opened at $0.91 on Wednesday. Hyperfine has a one year low of $0.76 and a one year high of $1.90. The company’s 50-day moving average is $1.07 and its 200 day moving average is $1.01. The company has a market capitalization of $66.54 million, a price-to-earnings ratio of -1.60 and a beta of 0.94.
Wall Street Analyst Weigh In
Separately, Wells Fargo & Company upped their target price on shares of Hyperfine from $1.10 to $1.29 and gave the stock an “equal weight” rating in a research report on Tuesday.
Hyperfine Company Profile
Hyperfine, Inc, a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors.
Read More
- Five stocks we like better than Hyperfine
- 3 Ways To Invest In Coffee, Other Than Drinking It
- 3 Stocks Returning Billions to Shareholders via Buybacks
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Tesla: 1 Reason to Love It, 1 Reason to Be Cautious
- What is the Euro STOXX 50 Index?
- 3 Stocks That Could Win Big From a 10% Cap on Credit Card Rates
Receive News & Ratings for Hyperfine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hyperfine and related companies with MarketBeat.com's FREE daily email newsletter.